Home
/
VIEMED HEALTHCARE, INC.
/
Financials
/
Quarterly
VIEMED HEALTHCARE, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that VIEMED HEALTHCARE, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$71.91M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$63.06M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$59.13M
May 7, 2025
Q3
2025
Sep 30, 2024
$58.00M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$54.97M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$50.59M
May 7, 2025
Q3
2024
Sep 30, 2023
$49.40M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$43.31M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$39.56M
May 6, 2024
Q3
2023
Sep 30, 2022
$35.76M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$33.31M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$32.26M
May 8, 2023
Q3
2022
Sep 30, 2021
$29.29M
Nov 1, 2022
Q2
2022
Jun 30, 2021
$27.40M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$28.42M
May 3, 2022
Q3
2021
Sep 30, 2020
$33.45M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$42.85M
Aug 3, 2021
Q1
2021
Mar 31, 2020
$23.81M
May 3, 2021
Q3
2020
Sep 30, 2019
$20.37M
Nov 4, 2020
Q2
2020
Jun 30, 2019
$20.33M
Aug 4, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.51M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$3.16M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$2.63M
May 7, 2025
Q3
2025
Sep 30, 2024
$3.88M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$1.47M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$1.60M
May 7, 2025
Q3
2024
Sep 30, 2023
$2.92M
Nov 6, 2024
Q3
2023
Jun 30, 2023
$2.33M
Nov 1, 2023
Q2
2024
Jun 30, 2023
$2.33M
Aug 7, 2024
Q2
2023
Mar 31, 2023
$1.52M
Aug 9, 2023
Q3
2023
Mar 31, 2023
$1.52M
Nov 1, 2023
Q1
2024
Mar 31, 2023
$1.52M
May 6, 2024
Q3
2023
Sep 30, 2022
$1.06M
Nov 1, 2023
Q3
2023
Jun 30, 2022
$967.0K
Nov 1, 2023
Q2
2023
Jun 30, 2022
$967.0K
Aug 9, 2023
Q3
2023
Mar 31, 2022
$1.76M
Nov 1, 2023
Q1
2023
Mar 31, 2022
$1.76M
May 8, 2023
Q2
2023
Mar 31, 2022
$1.76M
Aug 9, 2023
Q3
2022
Sep 30, 2021
$1.79M
Nov 1, 2022
Q2
2022
Jun 30, 2021
$1.57M
Aug 2, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$5.64M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$5.10M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$3.84M
May 7, 2025
Q3
2025
Sep 30, 2024
$5.63M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$3.62M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$2.20M
May 7, 2025
Q3
2024
Sep 30, 2023
$4.21M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$2.90M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$1.93M
May 6, 2024
Q3
2023
Sep 30, 2022
$1.47M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$1.00M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$2.25M
May 8, 2023
Q3
2022
Sep 30, 2021
$2.92M
Nov 1, 2022
Q2
2022
Jun 30, 2021
$2.66M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$1.33M
May 3, 2022
Q3
2021
Sep 30, 2020
$4.04M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$12.86M
Aug 3, 2021
Q1
2021
Mar 31, 2020
$4.62M
May 3, 2021
Q3
2020
Sep 30, 2019
$2.19M
Nov 4, 2020
Q2
2020
Jun 30, 2019
$1.66M
Aug 4, 2020